BBIO Similar Chart Price Prediction
The price of BBIO is predicted to go up -2.16%, based on the high correlation periods with CVS. The similarity of these two price pattern on the periods is 97.34%.
BBIO
CVS
Down: -2.16%Similarity: 97.34%
BBIO Revenue Forecast
BBIO EPS Forecast
BBIO FAQs
What is bull’s view on BBIO?
What is bear's view on BBIO?
What is BBIO revenue forecast for next quarter？
BBIO Analyst's Forecast
Cory Kasimov
Evercore ISI Group
Buy
2024-12-23
Price Target
$45 → $50
Upside
+80.54%
Evercore ISI raised the firm's price target on BridgeBio to $50 from $45 and keeps an Outperform rating on the shares following Attruby's approval and management discussions. The firm is updating its Attruby model to reflect 100% probability of success from 95%, pricing of $244,000 per year, and the firm's increasingly constructive view on Attruby's label, which could help future differentiation, the analyst tells investors in a research note. Evercore thinks its model is still conservative, leaving ample room for future upside.
Geoff Meacham
B of A Securities
Strong Buy
2024-11-25
Price Target
$42 → $45
Upside
+65.62%
Mani Foroohar
Leerink Partners
Buy
2024-10-17
Price Target
$47 → $46
Upside
+75.64%
